According to the report, therewere 18.1 million new cancer cases and 9.6 million cancer deaths in 2018,worldwide. One out of five men and one out of six women worldwide developcancer during their lifetime, and one out of eight men and one out of 11 womendie from the disease. Worldwide, the total number of people who are alivewithin 5 years of a cancer diagnosis, called the 5-year prevalence, isestimated to be 43.8 million.
However, several side effectsassociated with the use of hydrocortisone may inhibit the market growth. Forinstance, there is high chance of infection while utilizing hydrocortisone forreducing inflammation (swelling) in cancer patients as it prevents white bloodcells from entering into site of inflammation which in turn may compromiseability to produce immune response in patients’ body after infection incidence.
Hydrocortisone Market - RegionalInsights
On the basis of geography,hydrocortisone market is segmented into North America, Latin America, Europe,Asia Pacific, Middle East, and Africa. North America is expected to be dominantregion in the hydrocortisone market during forecast period. This is owing to thefact that U.S. has highly valued healthcare spending for various diseaseincluding cancer, COPS/asthma, arthritis and allergic reactions. OECD data in2016 suggests that U.S. has per capita healthcare expenditure of US$ 8,000.According to factsheet by Asthma and Allergy Foundation of America, there aremore than 50 million U.S. citizens affected by the various types of allergieseach year and it is 6th leading cause of chronic illness in the U.S.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/hydrocortisone-market-2376
According to same source, in2015, 8.2% of adults and 8.4% of children were diagnosed with hay fever. AsiaPacific region is expected to witness high growth over the forecast period.This is due to increasing number of deaths due to cancer in the region. According to data given by InternationalAgency for Cancer Research in 2018, the proportions of cancer deaths in Asiaand in Africa is 57.3% and 7.3%, respectively.
Hydrocortisone Market -Competitive Landscape
Key players operating in thehydrocortisone market are AstraZeneca plc, GlaxoSmithKline plc, Merck & Co.Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A, ActimisPharmaceuticals, and others.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2376
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
